Need professional-grade analysis? Visit stockanalysis.com
$4.47B
13.56
370
3.84%
Lepu Scientech Med Tech (2291) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at HKD12.09, down 1.71% from the previous close.
Over the past year, 2291 has traded between a low of HKD12.09 and a high of HKD27.46. The stock has lost 48.9% over this period. It is currently 56.0% below its 52-week high.
Lepu Scientech Med Tech has a market capitalization of $4.47B, with a price-to-earnings ratio of 13.56 and a dividend yield of 3.84%.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease. It operates through Occluder Business and Heart Valve Business segments. The company also research and develops heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent ductus arteriosus, patent foramen ovale, left atrial appendage, aortic and peripheral, and aortic and mitral valve occluder products; atrial septal puncture and procedural accessories; interatrial shunt device; mechanical circulatory support products; and hypertensive device treatment products. In addition, it is involved in manufacturing; technology development; and trading activities. The company serves its products through distributors and direct sales. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd.
Side-by-side comparison against top Healthcare peers.